Allene Fonseca
Dermatology · Orange, CANPI 1487008025
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,123 of the $5,422 with a category attached, or 76.1%. 25 manufacturers reported payments, led by AbbVie at 37.7% of the total. 2025 is the largest year on record at $2,627, 7.3 times the $359 reported in 2022.
Across 87 payments — averaging $62.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Regeneron Healthcare Solutions, Inc.$708
- Sanofi$663
- Dermavant Sciences, Inc.$241
- Johnson & Johnson$218
- Boehringer Ingelheim$213
- plus $1K from 19 others
What the payments were for
- Travel & lodging$1,29824%
- Food & beverage$4,12376%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $2,044 |
| Regeneron Healthcare Solutions, Inc. | 14 | $708 |
| Sanofi | 8 | $663 |
| Dermavant Sciences, Inc. | 2 | $241 |
| Johnson & Johnson | 5 | $218 |
| Boehringer Ingelheim | 5 | $213 |
| Galderma Laboratories, L.p. | 1 | $139 |
| Mallinckrodt Hospital Products Inc. | 1 | $126 |
| GSK | 1 | $122 |
| UCB, Inc. | 2 | $120 |
| Krystal Biotech Inc | 1 | $120 |
| Organon | 1 | $116 |
| Pfizer | 2 | $113 |
| Biofrontera Inc. | 3 | $77 |
| Sun Pharmaceutical Industries Inc. | 3 | $75 |
| Novartis | 3 | $73 |
| Helsinn Therapeutics (U.S.), Inc. | 4 | $64 |
| E.r. Squibb & Sons, L.L.C. | 1 | $34 |
| LEO Pharma Inc. | 1 | $29 |
| Incyte Corporation | 1 | $28 |
| Janssen Scientific Affairs, LLC | 1 | $27 |
| 180 Medical, Inc. | 1 | $22 |
| Fresenius Kabi USA, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,422 in reported general payments places this provider in the 70th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcipotriene | 14 | $3,003 |
| Betamethasone Dipropionate | 53 | $2,347 |
| Ammonium Lactate | 55 | $906 |
| Fluorouracil | 12 | $760 |
| Clindamycin Phosphate | 28 | $638 |
| Clobetasol Propionate | 22 | $624 |
| Ciclopirox | 13 | $577 |
| Triamcinolone Acetonide | 40 | $511 |
| Ketoconazole | 26 | $421 |
| Tretinoin | 11 | $355 |
| Hydrocortisone | 29 | $135 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Orange
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
- Tina BhutaniSan Francisco$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.